CN1682887A - Slimming and blood fat reducing preparation - Google Patents
Slimming and blood fat reducing preparation Download PDFInfo
- Publication number
- CN1682887A CN1682887A CN 200510037891 CN200510037891A CN1682887A CN 1682887 A CN1682887 A CN 1682887A CN 200510037891 CN200510037891 CN 200510037891 CN 200510037891 A CN200510037891 A CN 200510037891A CN 1682887 A CN1682887 A CN 1682887A
- Authority
- CN
- China
- Prior art keywords
- reducing
- blood fat
- fat
- preparation
- fat reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 17
- 210000004369 blood Anatomy 0.000 title claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 16
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 6
- 229930003944 flavone Natural products 0.000 claims abstract description 6
- 235000011949 flavones Nutrition 0.000 claims abstract description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 6
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 6
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 6
- 229930182490 saponin Natural products 0.000 claims abstract description 6
- 150000007949 saponins Chemical class 0.000 claims abstract description 6
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 244000068988 Glycine max Species 0.000 claims abstract description 5
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 5
- 244000269722 Thea sinensis Species 0.000 claims abstract description 5
- 240000008042 Zea mays Species 0.000 claims abstract description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 5
- 235000005822 corn Nutrition 0.000 claims abstract description 5
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 2
- 229920002752 Konjac Polymers 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 235000011201 Ginkgo Nutrition 0.000 claims description 5
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 5
- 150000002212 flavone derivatives Chemical class 0.000 claims description 5
- 229930187479 gypenoside Natural products 0.000 claims description 5
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- -1 haw flavone Chemical class 0.000 abstract 1
- 230000008821 health effect Effects 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000218628 Ginkgo Species 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical class C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241001161070 Calomela Species 0.000 description 1
- CBOKHFLBNZMMAA-UHFFFAOYSA-N Emodin anthrone Natural products OC1=CC(O)=CC2=CC3=CC(C)=CC(O)=C3C(O)=C21 CBOKHFLBNZMMAA-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 1
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000000578 anorexic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Chemical class CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Chemical class Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- LAJSXCAVRQXZIO-UHFFFAOYSA-N emodin anthrone Chemical compound C1=C(O)C=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O LAJSXCAVRQXZIO-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Abstract
The slimming and blood fat reducing preparation includes fine conjak powder, and one or several of haw flavone, gynostemma pentaphylla saponin, gingko extract, tea polyphenol, soybean saponin, fleeceflower root extract, cassia seed extract and corn embryo powder. The slimming and blood fat reducing preparation has medicine-food isogenesis components and may be taken for long time to result in health effect without toxic side effect.
Description
Technical field
The invention belongs to a kind of fat-reducing and blood fat reducing preparation, specifically is a kind of compound recipe glucomannoglycan preparation.
Background technology
Along with the mankind begin to enter the postindustrialization epoch, the mankind begin to be faced with diseases such as obesity, hypertension, hyperlipidemia, and these diseases become the arch enemy of man.The mankind have begun to develop the medicine of a lot of treatment obesities, hypertension, hyperlipidemia, but majority is a chemical drugs, certain therapeutic effect is arranged, but exist side effect big, can not take lastingly, end is covered in effect bounce-back etc. after the drug withdrawal, and promptly there is the tradition of tonic dietetic therapy in China from ancient times, utilize the little characteristics of Chinese herbal medicine side effect to bring into play its advantage aspect body-care exactly, be mankind's service.
Summary of the invention
The purpose of this invention is to provide a kind of fat-reducing and blood fat reducing preparation, based on the main component glucomannoglycan in the konjaku powder, cooperate other to have the Chinese herbal medicine of blood fat reducing, blood pressure reduction effect, the composition health product are mixed, be free from side effects, can take for a long time, and definite effect is obvious, is particularly useful for the health care of middle-aged and elderly people.
Technical scheme of the present invention is:
Fat-reducing and blood fat reducing preparation, wherein contain konjaku powder, it is characterized in that also containing in the following component one or more: Fructus Crataegi flavone, gypenoside, Semen Ginkgo extrac, tea polyphenols, soybean saponin, Radix Polygoni Multiflori extract, Semen Cassiae extract, corn plumule powder.
Described each component is that equal proportion is mixed.
The preparation of described fat-reducing and blood fat reducing preparation is various oral solid formulations such as oral liquid, granule, tablet, capsule, effervescent tablet.
Proportioning between each component in the preparation of the present invention can be arbitrarily.
In fat-reducing of the present invention and the blood fat reducing preparation, the konjaku powder main component is a glucomannoglycan, and content is greater than 60%, as the primary raw material of fat-reducing, lipid-lowering agent.
In fat-reducing of the present invention, the blood fat reducing preparation, other compositions that cooperate with konjaku powder: (select alcohol or the water extract of Fructus Crataegi for use, wherein Fructus Crataegi flavone content is about about 20-35% Fructus Crataegi flavone, and content is lower than 20%, goes back impurity as not containing, and can use; Content is higher than 35%, also can use; (choose alcohol or the water extract of Herb Gynostemmae Pentaphylli, wherein gypenoside content is about 20-50% to gypenoside, and content is lower than 20% or also can use greater than 50%, but must not contain harmful impurity; (contain Semen Ginkgo lactone and ginkgetin, by ginkgetin, content is about 10-40%, and content is less than 10% or also can use greater than 40%, but must not contain harmful impurity for alcohol of Semen Ginkgo or water extract; Tea polyphenols (choose the alcohol or the water extract of Folium Camelliae sinensis, all can use, but the strange rotten person of abnormal smells from the patient can not use by the tea polyphenols of various content; Soybean saponin (is chosen alcohol or the water extract of Semen sojae atricolor; Educate Calomelas (corn plumule powder); (total extract contains lecithin, chrysophanol, anthraquinone derivative etc. to Radix Polygoni Multiflori extract, must be through qualitative examination), Semen Cassiae extract (contain emodin anthrone, obtusin, the name lactone etc. of determining, the palpus qualitative examination) etc., can multiple ratio cooperate (such anoretic is divided into the series of products of multiple type).
Fat-reducing of the present invention, blood fat reducing preparation because composition wherein is doctor's food homology, so can take for a long time, has no side effect to health, and health-care effect is arranged, and be safe and reliable.
The specific embodiment
The component of fat-reducing of the present invention, blood fat reducing preparation:
Konjaku powder, Fructus Crataegi flavone, gypenoside, Semen Ginkgo extrac, tea polyphenols, soybean saponin, Radix Polygoni Multiflori extract, Semen Cassiae extract, corn plumule powder
Above component is assisted the excipient tabletting by waiting weight proportion to be mixed.
Above-mentioned preparation is carried out mouse experiment, conclusion: large and small dosage konjaku powder group and matched group are relatively, the fat weight average obviously reduces around mice body weight, the genitals, under high power microscope, adipose cell number seen in each visual field, konjaku powder group are obviously more than matched group, but cell volume is significantly less than matched group, illustrate that the fatty amount of konjaku powder group adipose cell is few, cell is crowded together.Experimental result shows that konjaku powder really can reduce the accumulation of fat, plays the effect of blood fat reducing and fat-reducing.
Claims (3)
1, fat-reducing and blood fat reducing preparation, wherein contain konjaku powder, it is characterized in that also containing in the following component one or more: Fructus Crataegi flavone, gypenoside, Semen Ginkgo extrac, tea polyphenols, soybean saponin, Radix Polygoni Multiflori extract, Semen Cassiae extract, corn plumule powder.
2, fat-reducing according to claim 1 and blood fat reducing preparation is characterized in that described each component is that equal proportion is mixed.
3, fat-reducing according to claim 1 and blood fat reducing preparation is characterized in that described preparation is oral liquid, granule, tablet, capsule, effervescent tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100378919A CN1331520C (en) | 2005-02-25 | 2005-02-25 | Slimming and blood fat reducing preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100378919A CN1331520C (en) | 2005-02-25 | 2005-02-25 | Slimming and blood fat reducing preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1682887A true CN1682887A (en) | 2005-10-19 |
| CN1331520C CN1331520C (en) | 2007-08-15 |
Family
ID=35262506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100378919A Active CN1331520C (en) | 2005-02-25 | 2005-02-25 | Slimming and blood fat reducing preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1331520C (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100381063C (en) * | 2005-12-19 | 2008-04-16 | 余内逊 | Preparation method of fat-reducing blood sugar-reducing sour soybean milk containing micro gingko leaf, Gymostamma pentaphyllum, haw and konnjaku powder |
| CN101253991B (en) * | 2008-04-09 | 2011-12-21 | 北京市科威华食品工程技术有限公司 | Soft capsules health care functional food product and method of preparing the same |
| CN102771788A (en) * | 2012-07-16 | 2012-11-14 | 北京绿源求证科技发展有限责任公司 | Dietetic healthcare slimming capsule |
| CN103404660A (en) * | 2013-08-06 | 2013-11-27 | 北京绿源求证科技发展有限责任公司 | Dietary therapy health-care weight-losing tea electuary |
| CN103432147A (en) * | 2013-08-29 | 2013-12-11 | 中国医学科学院生物医学工程研究所 | Oral medicinal preparation containing glycosyl modified polyphenolic substance and application of oral medicinal preparation |
| CN104041636A (en) * | 2014-06-25 | 2014-09-17 | 湖南中医药大学 | Traditional Chinese medicine health scented tea capable of beautifying and losing weight |
| CN104055969A (en) * | 2013-03-21 | 2014-09-24 | 漳州片仔癀药业股份有限公司 | Pharmaceutical composition capable of reducing weight |
| CN104415188A (en) * | 2013-08-19 | 2015-03-18 | 宣城柏维力生物工程有限公司 | L-carnitine tea polyphenol capsule and preparation method thereof |
| CN109275823A (en) * | 2018-10-16 | 2019-01-29 | 山东柳竖脂商贸有限公司 | A kind of weight losing meal-replacing solid beverage and preparation method thereof |
| CN113577176A (en) * | 2021-08-26 | 2021-11-02 | 湖北威曼斯科技有限公司 | Ointment for losing weight and slimming and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1335142A (en) * | 2000-07-26 | 2002-02-13 | 雷学军 | Weight reducing water containing natural medicinal component and its prepn |
-
2005
- 2005-02-25 CN CNB2005100378919A patent/CN1331520C/en active Active
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100381063C (en) * | 2005-12-19 | 2008-04-16 | 余内逊 | Preparation method of fat-reducing blood sugar-reducing sour soybean milk containing micro gingko leaf, Gymostamma pentaphyllum, haw and konnjaku powder |
| CN101253991B (en) * | 2008-04-09 | 2011-12-21 | 北京市科威华食品工程技术有限公司 | Soft capsules health care functional food product and method of preparing the same |
| CN102771788A (en) * | 2012-07-16 | 2012-11-14 | 北京绿源求证科技发展有限责任公司 | Dietetic healthcare slimming capsule |
| CN104055969A (en) * | 2013-03-21 | 2014-09-24 | 漳州片仔癀药业股份有限公司 | Pharmaceutical composition capable of reducing weight |
| CN104055969B (en) * | 2013-03-21 | 2017-12-12 | 漳州片仔癀药业股份有限公司 | A kind of pharmaceutical composition with antiobesity action |
| CN103404660A (en) * | 2013-08-06 | 2013-11-27 | 北京绿源求证科技发展有限责任公司 | Dietary therapy health-care weight-losing tea electuary |
| CN104415188A (en) * | 2013-08-19 | 2015-03-18 | 宣城柏维力生物工程有限公司 | L-carnitine tea polyphenol capsule and preparation method thereof |
| CN103432147B (en) * | 2013-08-29 | 2015-03-04 | 中国医学科学院生物医学工程研究所 | Oral medicinal preparation containing glycosyl modified polyphenolic substance and application of oral medicinal preparation |
| CN103432147A (en) * | 2013-08-29 | 2013-12-11 | 中国医学科学院生物医学工程研究所 | Oral medicinal preparation containing glycosyl modified polyphenolic substance and application of oral medicinal preparation |
| CN104041636A (en) * | 2014-06-25 | 2014-09-17 | 湖南中医药大学 | Traditional Chinese medicine health scented tea capable of beautifying and losing weight |
| CN104041636B (en) * | 2014-06-25 | 2016-04-27 | 湖南中医药大学 | Chinese medicine health-care jasmine tea of a kind of fat reducing of improving looks and preparation method thereof |
| CN109275823A (en) * | 2018-10-16 | 2019-01-29 | 山东柳竖脂商贸有限公司 | A kind of weight losing meal-replacing solid beverage and preparation method thereof |
| CN113577176A (en) * | 2021-08-26 | 2021-11-02 | 湖北威曼斯科技有限公司 | Ointment for losing weight and slimming and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1331520C (en) | 2007-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1331520C (en) | Slimming and blood fat reducing preparation | |
| CN101274042A (en) | Medicament composition for curing hyperlipemia and method of preparing the same | |
| CN1899342A (en) | Oral medicine for treating diabetes and its use | |
| CN101297888A (en) | Medicament composition and preparation thereof | |
| CN101062339A (en) | Medicine for treating diabetes | |
| CN101843694A (en) | Chinese medicament for treating chronic hepatitis | |
| CN100488539C (en) | Pharmaceutical composition for promoting blood circulation and preparation method thereof | |
| EP3823655B1 (en) | Compositions for the treatment of vulvodynia | |
| CN102145121B (en) | Chinese medical preparation assisting to adjusting blood sugar | |
| CN111110735A (en) | Lipid-lowering pharmaceutical composition, preparation method and application | |
| CN100409869C (en) | Externally-applied medicinal liquid for treating dermatosis | |
| CN103182008A (en) | Preparation method for traditional Chinese medicine used for stabilizing and reducing blood pressure | |
| WO2023100764A1 (en) | Composition for preventing, improving or alleviating symptoms relating to qi deficiency and/or blood deficiency | |
| CN102178798A (en) | Preparation for reducing blood fat, preventing and treating cardiovascular and cerebrovascular diseases | |
| CN101843778B (en) | Chinese medicament for treating ichthyosis | |
| CN101530559A (en) | Composition having weight-losing effect | |
| CN101843740B (en) | Chinese medicament for treating climacteric syndromes | |
| CN111110803A (en) | Traditional Chinese medicine composition with weight-losing and bowel-relaxing effects and preparation method and application thereof | |
| CN101337057A (en) | Zhiqing granule and preparation method thereof | |
| CN101480472A (en) | Medicament for reducing blood pressure and regulating blood fat and production method | |
| Xiang et al. | Scavenging and anti-fatigue activity of Wu-Wei-Zi aqueous extracts | |
| CN112089783B (en) | Application of traditional Chinese medicine composition in preparation of medicine for preventing or/and treating obesity | |
| Olatunde et al. | Progress of the components and biological activities of Morinda officinalis How | |
| CN102178813A (en) | Slimming beauty scraping oil and preparation method thereof | |
| CN106075189A (en) | A kind of Chinese medicine of blood fat reducing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HENAN JIUSHI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: WANG XIAOSHAN Effective date: 20080411 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20080411 Address after: Huixian City, Henan Province Zhou Bu village southeast nine potential pharmaceutical Co. Ltd. Patentee after: Henan Jiushi Pharmaceutical Co., Ltd. Address before: Mei Shan Road, Anhui University of Traditional Chinese Medicine, Anhui, Hefei College of pharmacy Patentee before: Wang Xiaoshan |
|
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: Huixian City, Henan province 453600 week package southeast nine pharmaceutical company limited potential Patentee after: Henan Jiushi Pharmaceutical Co., Ltd. Address before: Huixian City, Henan province 453600 week package southeast nine pharmaceutical company limited potential Patentee before: Henan Jiushi Pharmaceutical Co., Ltd. |
|
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20190308 Granted publication date: 20070815 |
|
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20220308 Granted publication date: 20070815 |
|
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20220308 Granted publication date: 20070815 |